[Asia Economy Reporter Gong Byung-sun] Samjin Pharmaceutical announced on the 7th that it will proceed with a facility expansion of the Osong plant worth 68 billion KRW. This amounts to 31.86% of Samjin Pharmaceutical's equity capital.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing